OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Abscopal effect of radiotherapy combined with immune checkpoint inhibitors
Yang Liu, Yinping Dong, Li Kong, et al.
Journal of Hematology & Oncology (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 381

Showing 1-25 of 381 citing articles:

Inflammation and tumor progression: signaling pathways and targeted intervention
Huakan Zhao, Lei Wu, Guifang Yan, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1636

Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
Rong Tang, Jin Xu, Bo Zhang, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 976

Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
Ming Yi, Xiaoli Zheng, Mengke Niu, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 860

A Review of Cancer Immunotherapy: From the Past, to the Present, to the Future
Khashayar Esfahani, Liya Roudaia, Najwa Buhlaiga, et al.
Current Oncology (2020) Vol. 27, Iss. 12, pp. 87-97
Open Access | Times Cited: 806

Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Zengfu Zhang, Xu Liu, Dawei Chen, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 366

Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy
Anping Li, Ming Yi, Shuang Qin, et al.
Journal of Hematology & Oncology (2019) Vol. 12, Iss. 1
Open Access | Times Cited: 288

Radiotherapy treatment for lung cancer: Current status and future directions
Shalini Vinod, Eric Hau
Respirology (2020) Vol. 25, Iss. S2, pp. 61-71
Open Access | Times Cited: 267

HMGB1 in inflammation and cancer
Shumin Wang, Yi Zhang
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 191

Neoadjuvant immunotherapy for non–small cell lung cancer: State of the art
Jin U. Kang, Chao Zhang, Wen‐Zhao Zhong
Cancer Communications (2021) Vol. 41, Iss. 4, pp. 287-302
Open Access | Times Cited: 118

Nanoparticle‐Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor Efficacy
Wenyao Zhen, Ralph R. Weichselbaum, Wenbin Lin
Advanced Materials (2022) Vol. 35, Iss. 21
Open Access | Times Cited: 89

Recent developments in immunotherapy for gastrointestinal tract cancers
Xiaoyi Chong, Yelizhati Madeti, Jieyuan Cai, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 21

Advancements in immunotherapy for gastric cancer: Unveiling the potential of immune checkpoint inhibitors and emerging strategies
Jiawei Song, Jun Zhu, Yu Jiang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189277-189277
Closed Access | Times Cited: 2

Radiotherapy-Related Lymphopenia Affects Overall Survival in Patients With Lung Cancer
A. Abravan, C. Faivre‐Finn, Jason Kennedy, et al.
Journal of Thoracic Oncology (2020) Vol. 15, Iss. 10, pp. 1624-1635
Open Access | Times Cited: 134

Modulating inflammation for cancer therapy
Birgit Ritter, Florian R. Greten
The Journal of Experimental Medicine (2019) Vol. 216, Iss. 6, pp. 1234-1243
Open Access | Times Cited: 133

Temozolomide Induced Hypermutation in Glioma: Evolutionary Mechanisms and Therapeutic Opportunities
Paul Daniel, Siham Sabri, Ahmad Chaddad, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 132

The role of neoantigen in immune checkpoint blockade therapy
Ming Yi, Shuang Qin, Weiheng Zhao, et al.
Experimental Hematology and Oncology (2018) Vol. 7, Iss. 1
Open Access | Times Cited: 119

Abscopal effect in radioimmunotherapy
Milad Ashrafizadeh, Bagher Farhood, Ahmed Eleojo Musa, et al.
International Immunopharmacology (2020) Vol. 85, pp. 106663-106663
Closed Access | Times Cited: 112

Immune checkpoint inhibitor combinations: Current efforts and important aspects for success
Edo Kon, Itai Benhar
Drug Resistance Updates (2019) Vol. 45, pp. 13-29
Closed Access | Times Cited: 104

Damage-associated molecular patterns in tumor radiotherapy
Milad Ashrafizadeh, Bagher Farhood, Ahmed Eleojo Musa, et al.
International Immunopharmacology (2020) Vol. 86, pp. 106761-106761
Closed Access | Times Cited: 99

The Abscopal Effect of Radiation Therapy
Daniel J. Craig, Nisha S. Nanavaty, Monika Devanaboyina, et al.
Future Oncology (2021) Vol. 17, Iss. 13, pp. 1683-1694
Open Access | Times Cited: 93

Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
Changhoon Choi, Gyu Sang Yoo, Won Kyung Cho, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 20, pp. 2416-2429
Open Access | Times Cited: 80

Radiation-induced small extracellular vesicles as “carriages” promote tumor antigen release and trigger antitumor immunity
Wanzun Lin, Yanyan Xu, Xiaochuan Chen, et al.
Theranostics (2020) Vol. 10, Iss. 11, pp. 4871-4884
Open Access | Times Cited: 78

Exosomal PD-L1: New Insights Into Tumor Immune Escape Mechanisms and Therapeutic Strategies
Kaijian Zhou, Shu Guo, Fei Li, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 77

Gut microbiota modulate radiotherapy-associated antitumor immune responses against hepatocellular carcinoma Via STING signaling
Zongjuan Li, Yang Zhang, Weifeng Hong, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 57

Effective Combinations of Immunotherapy and Radiotherapy for Cancer Treatment
Siting Yu, Yang Wang, Ping He, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 53

Page 1 - Next Page

Scroll to top